Annexin V-CF Blue 7-AAD Apoptosis Staining / Detection Kit
Be the first to review this product! Submit a review
|
(17 Publications)
- Flow Cyt
Supplier Data
Flow Cytometry - Annexin V-CF Blue 7-AAD Apoptosis Staining / Detection Kit (AB214663)
Abcam's Apoptosis Detection (Annexin V-CF Blue 7-AAD) Kit ab214663 Jurkat cells (T-cell leukemia, human) untreated.
- Flow Cyt
Unknown
Flow Cytometry - Annexin V-CF Blue 7-AAD Apoptosis Staining / Detection Kit (AB214663)
Abcam’s Apoptosis Detection (Annexin V-CF Blue 7-AAD) Kit Jurkat cells (T-cell leukemia, human) treated with 6 μM camptothecin for four hours.
Abcam's Apoptosis Detection (Annexin V-CF Blue 7-AAD) Kit Jurkat cells (T-cell leukemia, human) treated with 6 μM camptothecin for four hours.
Product details
Annexin V-CF Blue 7-AAD Apoptosis Staining / Detection Kit (ab214663) contains Annexin V labeled with CF Blue, which allows the identification and quantitation of apoptotic cells on a single-cell basis by flow cytometry. Simultaneous staining of cells with Annexin V–CF Blue (blue fluorescence) and the non-vital dye 7-aminoactinomycin D (7-AAD) (red fluorescence) allows the discrimination of intact cells (Annexin V-CF Blue negative, 7-AAD Staining Solution negative), early apoptotic (Annexin V-CF Blue positive, 7-AAD Staining Solution negative) and late apoptotic or necrotic cells (Annexin V-CF Blue positive, 7-AAD Staining Solution positive).
CF-Blue can be used as direct replacement for Pacific Blue™ or similar blue dyes.
For more apoptosis assays, review the full set of Annexin V assays, or the apoptosis assay and apoptosis marker guide.
Exposure of phosphatidylserine (PS) on the external surface of the cell membrane has been reported to occur in the early phases of apoptotic cell death, during which the cell membrane remains intact. In leukocyte apoptosis, PS on the outer surface of the cell marks the cell for recognition and phagocytosis by macrophages. The Annexin V protein has a high affinity for PS, and shows minimal binding to phosphatidylcholine and sphingomyelin. Changes in PS asymmetry, which can be analyzed by measuring annexin V binding to the cell membrane, are generally observed before morphological changes associated with apoptosis occurred and before membrane integrity is lost.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Cells 13: PubMed38727309
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in nutrition 11:1372982 PubMed38533461
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37894734
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36835538
2023
Applications
Unspecified application
Species
Unspecified reactive species
Immunity, inflammation and disease 11:e590 PubMed36480653
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 123:1663-1673 PubMed36271841
2022
Applications
Unspecified application
Species
Unspecified reactive species
Translational neurodegeneration 11:16 PubMed35272709
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 12: PubMed35327614
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular oncology 16:1777-1794 PubMed34856072
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed34639012
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com